Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ADAM9 CORD9, KIAA0021, MCMP, MDC9, Mltng ENSG00000168615 ADAM metallopeptidase domain 9 8 38996869-39105144 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA004000 Approved Endoplasmic reticulum
Vesicles Liver cancer:7.21e-6 (unfavourable), Pancreatic cancer:2.52e-5 (unfavourable), Breast cancer:1.14e-4 (unfavourable), Cervical cancer:2.25e-4 (unfavourable), Renal cancer:3.99e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 116.7 ADAMTS9 KIAA1312 ENSG00000163638 ADAM metallopeptidase with thrombospondin type 1 motif, 9 3 64515654-64688000 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA028567, HPA028577, HPA028601 Approved Supported Endoplasmic reticulum
Vesicles Expressed in all Tissue enhanced placenta: 45.0 adipose tissue: 31.9 AGPAT1 LPAAT-alpha ENSG00000204310 1-acylglycerol-3-phosphate O-acyltransferase 1 6 32168212-32178096 Enzymes, Predicted membrane proteins Evidence at protein level HPA048478, HPA073355 Approved Supported Endoplasmic reticulum
Rods & Rings Breast cancer:1.93e-4 (unfavourable), Endometrial cancer:5.21e-4 (unfavourable) Expressed in all Mixed epididymis: 51.4 AKR1C1 DD1, DDH, DDH1, HAKRC, MBAB ENSG00000187134 Aldo-keto reductase family 1, member C1 10 4963253-5107522 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB047303, HPA068265 Uncertain Supported Endoplasmic reticulum
Cytosol Renal cancer:8.03e-9 (favourable), Liver cancer:1.56e-4 (unfavourable), Cervical cancer:3.05e-4 (favourable) Tissue enhanced Expressed in all liver: 406.4 ALB ENSG00000163631 Albumin 4 73397114-73421412 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB006262, HPA031024, HPA031025 Supported Validated Endoplasmic reticulum
Golgi apparatus Stomach cancer:7.87e-4 (unfavourable) Tissue enriched Tissue enriched 221 liver: 105632.0 kidney: 478.5 ALG1 HMAT1, HMT-1 ENSG00000033011 ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase 16 5033960-5087379 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA060392 Approved Approved Nucleoli fibrillar center
Endoplasmic reticulum Colorectal cancer:5.79e-4 (favourable), Testis cancer:6.93e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 32.8 ALG1L2 ENSG00000251287 ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like 2 3 130081831-130113227 Predicted intracellular proteins Evidence at protein level HPA060392 Uncertain Uncertain Nucleoli fibrillar center
Endoplasmic reticulum Ovarian cancer:7.75e-4 (favourable) Mixed Tissue enhanced epididymis: 1.1;spleen: 1.1 breast,fallopian tube: 0.3 AMFR gp78, RNF45 ENSG00000159461 Autocrine motility factor receptor, E3 ubiquitin protein ligase 16 56361452-56425538 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB026381, HPA029018, HPA077835 Approved Supported Endoplasmic reticulum
Golgi apparatus Expressed in all Expressed in all testis: 154.3 ANKLE2 KIAA0692, Lem4, LEMD7 ENSG00000176915 Ankyrin repeat and LEM domain containing 2 12 132725503-132761888 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA003602, HPA074838 Uncertain Supported Endoplasmic reticulum
Plasma membrane Renal cancer:1.90e-8 (unfavourable), Liver cancer:3.97e-6 (unfavourable) Expressed in all Expressed in all testis: 80.1 ARHGAP5 GFI2, p190-B, p190BRhoGAP, RhoGAP5 ENSG00000100852 Rho GTPase activating protein 5 14 32076114-32159728 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA046993, HPA056507 Approved Supported Endoplasmic reticulum
Cytosol Renal cancer:3.97e-8 (favourable) Expressed in all Expressed in all thyroid gland: 117.3 ASGR2 CLEC4H2 ENSG00000161944 Asialoglycoprotein receptor 2 17 7101322-7115700 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014899, HPA015998 Supported Supported Endoplasmic reticulum
Plasma membrane Tissue enriched Tissue enriched 11 liver: 317.4 gallbladder: 28.1 BGN DSPG1, SLRR1A ENSG00000182492 Biglycan X 153494939-153509554 Predicted secreted proteins Evidence at protein level HPA003157, CAB003678 Supported Approved Endoplasmic reticulum
Golgi apparatus Renal cancer:6.00e-8 (unfavourable) Expressed in all Mixed gallbladder: 503.2 BTG4 PC3B ENSG00000137707 B-cell translocation gene 4 11 111467526-111512354 Predicted intracellular proteins Evidence at transcript level HPA057157 Approved Endoplasmic reticulum
Golgi apparatus Not detected Tissue enriched 17 testis: 47.2 fallopian tube: 2.7 C10orf12 DKFZP564P1916, FLJ13022 ENSG00000155640 Chromosome 10 open reading frame 12 10 96981284-96986212 Predicted intracellular proteins Evidence at protein level HPA038954 Approved Approved Nucleoplasm
Endoplasmic reticulum Mixed Mixed bone marrow: 4.7 C11orf58 SMAP ENSG00000110696 Chromosome 11 open reading frame 58 11 16613132-16756881 Predicted intracellular proteins Evidence at protein level HPA036591, HPA076406 Uncertain Approved Nucleoplasm
Endoplasmic reticulum Liver cancer:5.84e-5 (unfavourable) Expressed in all Expressed in all thyroid gland: 217.3 CAPZA2 CAPPA2, CAPZ ENSG00000198898 Capping protein (actin filament) muscle Z-line, alpha 2 7 116811070-116922049 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA007470, HPA007643 Uncertain Approved Endoplasmic reticulum
Cytosol Renal cancer:3.65e-6 (favourable), Liver cancer:9.34e-5 (unfavourable) Expressed in all Expressed in all smooth muscle: 41.9 CAST ENSG00000153113 Calpastatin 5 96525267-96779595 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB009491, HPA036881, HPA036882 Approved Validated Endoplasmic reticulum
Cytosol Stomach cancer:1.20e-5 (unfavourable), Pancreatic cancer:9.27e-5 (unfavourable), Urothelial cancer:4.98e-4 (unfavourable) Expressed in all Expressed in all esophagus: 403.4 CCPG1 CPR8, KIAA1254 ENSG00000260916 Cell cycle progression 1 15 55340032-55408510 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA009432, HPA026861 Approved Approved Endoplasmic reticulum
Golgi apparatus Stomach cancer:5.02e-5 (unfavourable), Renal cancer:5.07e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 139.9 CDS2 ENSG00000101290 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 20 5126786-5197887 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA019698 Approved Approved Endoplasmic reticulum
Cytosol Renal cancer:3.53e-9 (favourable) Expressed in all Expressed in all cerebral cortex: 49.1 CERS2 FLJ10243, LASS2, SP260 ENSG00000143418 Ceramide synthase 2 1 150960583-150975004 Predicted membrane proteins Evidence at protein level HPA027262 Approved Supported Nuclear membrane
Endoplasmic reticulum Expressed in all Expressed in all liver: 408.6 CES3 ES31, FLJ21736 ENSG00000172828 Carboxylesterase 3 16 66961237-66975148 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA041008, HPA041307 Approved Approved Nuclear membrane
Endoplasmic reticulum Liver cancer:7.26e-5 (favourable) Mixed Tissue enhanced colon: 37.9;duodenum: 31.3;rectum: 34.8 small intestine: 27.1 CLEC14A C14orf27 ENSG00000176435 C-type lectin domain family 14, member A 14 38254103-38256369 Predicted membrane proteins Evidence at protein level HPA039468, HPA048119 Uncertain Supported Endoplasmic reticulum
Golgi apparatus Head and neck cancer:4.13e-6 (favourable) Expressed in all Tissue enhanced lung: 76.4 adipose tissue: 40.9 COL22A1 ENSG00000169436 Collagen, type XXII, alpha 1 8 138588235-138914006 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA024830 Approved Supported Endoplasmic reticulum
Vesicles Lung cancer:2.13e-6 (unfavourable), Glioma:3.62e-4 (unfavourable) Mixed Tissue enhanced adrenal gland: 9.8 prostate: 4.8 COL4A3 ENSG00000169031 Collagen, type IV, alpha 3 (Goodpasture antigen) 2 227164565-227314792 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA042064 Approved Approved Endoplasmic reticulum
Vesicles Renal cancer:2.51e-7 (favourable) Group enriched Tissue enhanced thyroid gland: 26.7 lung: 22.4 COMT ENSG00000093010 Catechol-O-methyltransferase 22 19941607-19969975 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA001169, CAB011233 Supported Approved Endoplasmic reticulum
Vesicles Endometrial cancer:3.68e-4 (favourable), Prostate cancer:5.67e-4 (favourable), Renal cancer:9.76e-4 (unfavourable) Expressed in all Expressed in all placenta: 172.0 CREB3L2 BBF2H7, TCAG_1951439 ENSG00000182158 CAMP responsive element binding protein 3-like 2 7 137874979-138002067 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level HPA015068, HPA015534 Uncertain Supported Nucleoplasm
Endoplasmic reticulum Expressed in all Expressed in all thyroid gland: 109.9 CTD-2192J16.24 ENSG00000269590 19 12664828-12669397 Predicted intracellular proteins Evidence at protein level HPA065685 Approved Nuclear membrane
Endoplasmic reticulum Not detected Tissue enhanced lymph node: 2.0 cerebral cortex,duodenum: 1.3 DDRGK1 C20orf116, dJ1187M17.3 ENSG00000198171 DDRGK domain containing 1 20 3190350-3204685 Predicted intracellular proteins Evidence at protein level HPA013373, HPA013705 Approved Supported Nucleoli
Endoplasmic reticulum Renal cancer:2.01e-5 (favourable) Expressed in all Expressed in all adrenal gland: 72.7 DGAT1 ARGP1, DGAT ENSG00000185000 Diacylglycerol O-acyltransferase 1 8 144314584-144326910 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level CAB032853 Supported Approved Nucleoli
Endoplasmic reticulum Expressed in all Tissue enhanced duodenum: 73.2;small intestine: 76.7 adipose tissue: 20.0 DHCR7 SLOS ENSG00000172893 7-dehydrocholesterol reductase 11 71428193-71452868 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level HPA044280 Approved Supported Endoplasmic reticulum
Cytosol Renal cancer:6.93e-7 (favourable), Urothelial cancer:5.67e-4 (unfavourable) Expressed in all Expressed in all adrenal gland: 116.0 DNAJB9 MDG1 ENSG00000128590 DnaJ (Hsp40) homolog, subfamily B, member 9 7 108569568-108574850 Predicted secreted proteins Evidence at protein level HPA040967, HPA041553 Supported Approved Endoplasmic reticulum
Cytosol Expressed in all Expressed in all thyroid gland: 113.1 EIF2S2 EIF2, EIF2beta, PPP1R67 ENSG00000125977 Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa 20 34088298-34112332 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB034415, HPA041262, HPA041332 Approved Supported Nucleoli
Endoplasmic reticulum Renal cancer:9.64e-10 (unfavourable), Liver cancer:3.23e-5 (unfavourable), Endometrial cancer:8.74e-4 (unfavourable) Expressed in all Expressed in all placenta: 74.0 EMD LEMD5, STA ENSG00000102119 Emerin X 154379197-154381523 Disease related genes, Predicted membrane proteins Evidence at protein level HPA000609, CAB001545, CAB002029, CAB062552 Supported Validated Nuclear membrane
Endoplasmic reticulum Expressed in all Expressed in all fallopian tube: 32.3 ESYT1 FAM62A, KIAA0747, MBC2 ENSG00000139641 Extended synaptotagmin-like protein 1 12 56118250-56144671 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA016858, HPA076926 Approved Supported Endoplasmic reticulum
Vesicles Renal cancer:3.86e-4 (favourable) Expressed in all Expressed in all adipose tissue: 114.2 FAF2 ETEA, KIAA0887, UBXD8, UBXN3B ENSG00000113194 Fas associated factor family member 2 5 176447628-176510074 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA065968, HPA073828 Validated Endoplasmic reticulum
Lipid droplets Lung cancer:1.38e-4 (unfavourable), Liver cancer:1.79e-4 (unfavourable) Expressed in all Expressed in all parathyroid gland: 41.2 FAM132B C1QTNF15, CTRP15, FLJ37034 ENSG00000178752 Family with sequence similarity 132, member B 2 238158982-238168900 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level HPA077259 Approved Endoplasmic reticulum
Microtubule organizing center Renal cancer:2.46e-4 (unfavourable), Endometrial cancer:3.75e-4 (unfavourable) Tissue enhanced Group enriched 8 testis: 17.1;thyroid gland: 40.6 appendix: 3.5 FAM134B FLJ20152, JK1 ENSG00000154153 Family with sequence similarity 134, member B 5 16473038-16617058 Disease related genes, Predicted membrane proteins Evidence at protein level HPA012077 Supported Nuclear bodies
Endoplasmic reticulum Renal cancer:5.25e-10 (favourable) Expressed in all Expressed in all heart muscle: 64.0 FMO5 ENSG00000131781 Flavin containing monooxygenase 5 1 147175351-147243050 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA012373 Supported Supported Endoplasmic reticulum
Cytosol Renal cancer:1.34e-6 (favourable) Tissue enriched Tissue enhanced liver: 324.2 small intestine: 77.0 GNPTG C16orf27, c316G12.3, CAB56184, GNPTAG ENSG00000090581 N-acetylglucosamine-1-phosphate transferase, gamma subunit 16 1351923-1364113 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level HPA004055 Approved Approved Endoplasmic reticulum
Cytosol Expressed in all Expressed in all adrenal gland: 66.6 HECW2 KIAA1301, NEDL2 ENSG00000138411 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 2 196194370-196593692 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA034609 Uncertain Approved Nucleoli fibrillar center
Endoplasmic reticulum Renal cancer:5.18e-5 (unfavourable) Mixed Mixed placenta: 15.7 INF2 C14orf151, C14orf173, MGC13251 ENSG00000203485 Inverted formin, FH2 and WH2 domain containing 14 104689606-104722535 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA000724 Approved Approved Nuclear bodies
Endoplasmic reticulum Liver cancer:8.18e-4 (unfavourable) Expressed in all Expressed in all stomach: 56.6 ISOC1 CGI-111 ENSG00000066583 Isochorismatase domain containing 1 5 129094751-129114028 Predicted intracellular proteins Evidence at protein level HPA070307 Approved Endoplasmic reticulum
Vesicles Expressed in all Expressed in all endometrium: 174.3 ITPR2 CFAP48, IP3R2 ENSG00000123104 Inositol 1,4,5-trisphosphate receptor, type 2 12 26336515-26833198 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA059144, HPA062260 Uncertain Supported Nucleus
Endoplasmic reticulum Expressed in all Mixed parathyroid gland: 25.7 KCTD20 C6orf69, dJ108K11.3, MGC14254 ENSG00000112078 Potassium channel tetramerization domain containing 20 6 36442767-36491143 Predicted intracellular proteins Evidence at protein level HPA030092 Approved Approved Nuclear speckles
Endoplasmic reticulum Glioma:7.39e-4 (favourable), Renal cancer:8.02e-4 (unfavourable), Liver cancer:8.32e-4 (unfavourable), Thyroid cancer:9.31e-4 (unfavourable) Expressed in all Expressed in all adipose tissue: 46.7 KIAA1715 LNP, LNP1, Ul, ulnaless ENSG00000144320 KIAA1715 2 175923892-176002839 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014205 Approved Supported Nucleoplasm
Endoplasmic reticulum Expressed in all Expressed in all testis: 45.8 LAMC1 LAMB2 ENSG00000135862 Laminin, gamma 1 (formerly LAMB2) 1 183023460-183145592 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA001908, HPA001909, CAB004486, CAB078163 Supported Approved Endoplasmic reticulum
Plasma membrane Urothelial cancer:8.85e-5 (unfavourable) Expressed in all Tissue enhanced placenta: 330.2 smooth muscle: 145.7 LCLAT1 AGPAT8, ALCAT1, FLJ37965, LYCAT ENSG00000172954 Lysocardiolipin acyltransferase 1 2 30447226-30644225 Enzymes, Predicted membrane proteins Evidence at protein level HPA031880, HPA049217 Uncertain Supported Endoplasmic reticulum
Cytosol Liver cancer:8.72e-4 (unfavourable), Head and neck cancer:9.67e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 19.2 LCTL FLJ33279, KLG, KLPH ENSG00000188501 Lactase-like 15 66547179-66565979 Cancer-related genes, Predicted membrane proteins Evidence at protein level HPA071640 Approved Endoplasmic reticulum
Plasma membrane Group enriched Mixed cerebral cortex: 1.0 LPCAT1 AGPAT10, AGPAT9, AYTL2, FLJ12443 ENSG00000153395 Lysophosphatidylcholine acyltransferase 1 5 1456480-1523977 Enzymes, Predicted membrane proteins Evidence at protein level HPA012501, HPA022268 Supported Supported Endoplasmic reticulum
Lipid droplets Liver cancer:1.88e-8 (unfavourable), Renal cancer:2.64e-7 (unfavourable), Pancreatic cancer:4.90e-5 (favourable), Cervical cancer:7.11e-5 (unfavourable), Endometrial cancer:3.67e-4 (unfavourable) Expressed in all Tissue enhanced lung: 19.2;spleen: 15.1 cerebral cortex: 4.4 LPCAT2 AGPAT11, AYTL1, FLJ20481, LysoPAFAT ENSG00000087253 Lysophosphatidylcholine acyltransferase 2 16 55508998-55586670 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA007891, HPA008433 Supported Supported Validated Endoplasmic reticulum
Lipid droplets Endometrial cancer:8.03e-6 (favourable), Colorectal cancer:3.43e-4 (favourable) Expressed in all Tissue enhanced thyroid gland: 141.9 bone marrow: 56.6 LRAT LCA14 ENSG00000121207 Lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) 4 154626945-154753118 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA008397, HPA070726 Uncertain Uncertain Endoplasmic reticulum
Golgi apparatus Mixed Mixed thyroid gland: 2.3 LYPD3 C4.4A ENSG00000124466 LY6/PLAUR domain containing 3 19 43460787-43465660 Predicted membrane proteins Evidence at protein level HPA041529, HPA041797, HPA077859 Supported Approved Endoplasmic reticulum
Vesicles Lung cancer:7.86e-5 (unfavourable) Tissue enhanced Group enriched 5 esophagus: 676.5;skin: 594.5 tonsil: 118.9 MATN3 EDM5, HOA ENSG00000132031 Matrilin 3 2 19992111-20012694 Disease related genes, Predicted secreted proteins Evidence at protein level HPA051250 Approved Endoplasmic reticulum
Golgi apparatus Stomach cancer:4.74e-5 (unfavourable), Liver cancer:8.62e-5 (unfavourable), Cervical cancer:1.41e-4 (unfavourable) Expressed in all Tissue enhanced lung: 20.2;placenta: 16.4 seminal vesicle: 6.2 MGST1 GST12, MGST-I ENSG00000008394 Microsomal glutathione S-transferase 1 12 16347142-16609259 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA044840 Supported Approved Endoplasmic reticulum
Mitochondria Thyroid cancer:1.97e-4 (favourable), Renal cancer:7.45e-4 (unfavourable) Expressed in all Expressed in all liver: 1596.8 MMP19 MMP18, RASI-1 ENSG00000123342 Matrix metallopeptidase 19 12 55835433-55842966 Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level HPA070804 Approved Endoplasmic reticulum
Vesicles Renal cancer:8.56e-9 (unfavourable) Expressed in all Tissue enhanced adipose tissue: 63.1;gallbladder: 97.5 placenta: 27.9 MPDU1 CDGIf, Lec35, PQLC5, SL15 ENSG00000129255 Mannose-P-dolichol utilization defect 1 17 7583529-7592789 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014845 Uncertain Supported Endoplasmic reticulum
Mitochondria Expressed in all Expressed in all rectum: 70.2 MSH5 ENSG00000204410 MutS homolog 5 6 31739948-31762834 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA062688 Approved Endoplasmic reticulum
Vesicles Mixed Mixed skin: 1.8 MXRA7 FLJ46603, PS1TP1, TMAP1 ENSG00000182534 Matrix-remodelling associated 7 17 76672551-76711016 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA044819 Uncertain Approved Nucleus
Endoplasmic reticulum Urothelial cancer:1.80e-5 (unfavourable), Liver cancer:4.70e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 454.2 NSDHL H105e3, SDR31E1, XAP104 ENSG00000147383 NAD(P) dependent steroid dehydrogenase-like X 152830967-152869729 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA000248, HPA000571 Supported Validated Endoplasmic reticulum
Lipid droplets Renal cancer:6.09e-5 (favourable), Liver cancer:5.04e-4 (unfavourable), Cervical cancer:5.65e-4 (favourable) Expressed in all Expressed in all epididymis: 53.2 P4HA2 C-P4Halpha(II) ENSG00000072682 Prolyl 4-hydroxylase, alpha polypeptide II 5 132191838-132295315 Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins Evidence at protein level HPA016997, HPA027824, CAB062557 Supported Validated Endoplasmic reticulum
Vesicles Renal cancer:2.77e-7 (unfavourable), Cervical cancer:1.24e-5 (unfavourable), Urothelial cancer:3.12e-4 (unfavourable) Expressed in all Expressed in all epididymis: 93.7 PAH PH ENSG00000171759 Phenylalanine hydroxylase 12 102836885-102958410 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level HPA028407, HPA031642 Supported Approved Endoplasmic reticulum
Vesicles Liver cancer:4.30e-4 (favourable) Tissue enriched Tissue enhanced kidney: 500.3;liver: 720.9 gallbladder: 126.2 PAPPA2 PAPP-A2, PAPPE, PLAC3 ENSG00000116183 Pappalysin 2 1 176463171-176845605 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA018412, HPA018430 Supported Approved Endoplasmic reticulum
Vesicles Mixed Tissue enriched 8 placenta: 82.1 cervix, uterine: 10.8 PDIA6 ERp5, P5, TXNDC7 ENSG00000143870 Protein disulfide isomerase family A, member 6 2 10783391-10837977 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level CAB034347, HPA034652, HPA034653 Supported Supported Endoplasmic reticulum
Cytosol Renal cancer:2.51e-6 (unfavourable), Liver cancer:3.63e-5 (unfavourable), Head and neck cancer:1.20e-4 (unfavourable), Cervical cancer:1.80e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 589.5 PDZK1 NHERF3, PDZD1 ENSG00000174827 PDZ domain containing 1 1 145670852-145708148 Predicted intracellular proteins Evidence at protein level HPA005755, HPA006155, CAB008971 Supported Supported Endoplasmic reticulum
Vesicles Renal cancer:2.54e-7 (favourable) Group enriched Tissue enhanced kidney: 557.9;small intestine: 129.6 duodenum: 70.9 PGRMC1 HPR6.6 ENSG00000101856 Progesterone receptor membrane component 1 X 119236245-119244466 Predicted membrane proteins Evidence at protein level HPA002877 Supported Approved Nucleoli
Endoplasmic reticulum Head and neck cancer:3.02e-4 (unfavourable) Expressed in all Expressed in all liver: 339.5 PIGV FLJ20477 ENSG00000060642 Phosphatidylinositol glycan anchor biosynthesis, class V 1 26787472-26798398 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA054181 Approved Endoplasmic reticulum
Cytosol Renal cancer:7.60e-7 (favourable) Expressed in all Expressed in all testis: 83.5 PPIB CYPB, OI9 ENSG00000166794 Peptidylprolyl isomerase B (cyclophilin B) 15 64155812-64163205 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins Evidence at protein level CAB011487, HPA012720 Supported Supported Nucleus
Endoplasmic reticulum Renal cancer:2.02e-11 (unfavourable), Endometrial cancer:1.56e-5 (favourable) Expressed in all Expressed in all thyroid gland: 852.0 PRAF2 JM4 ENSG00000243279 PRA1 domain family, member 2 X 49071156-49074071 Predicted membrane proteins Evidence at protein level HPA002859, HPA005504, CAB011655 Supported Approved Endoplasmic reticulum
Vesicles Liver cancer:1.66e-6 (unfavourable), Pancreatic cancer:4.88e-6 (favourable), Renal cancer:5.83e-6 (unfavourable), Lung cancer:2.81e-4 (favourable), Cervical cancer:7.42e-4 (favourable) Expressed in all Expressed in all epididymis: 181.8 PRDX4 AOE37-2 ENSG00000123131 Peroxiredoxin 4 X 23664262-23686399 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level CAB008659, CAB027389, CAB047362 Supported Supported Endoplasmic reticulum
Cytosol Renal cancer:1.33e-6 (unfavourable) Expressed in all Expressed in all pancreas: 239.4 PRSS2 TRY2 ENSG00000275896 Protease, serine, 2 (trypsin 2) 7 142748662-142774564 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA062452, HPA063471 Supported Approved Endoplasmic reticulum
Vesicles Breast cancer:2.32e-4 (favourable) Tissue enriched Tissue enriched 53 pancreas: 30691.5 small intestine: 579.8 PRSS3 PRSS4, TRY3, TRY4 ENSG00000010438 Protease, serine, 3 9 33750466-33799231 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA062452, HPA063471 Supported Approved Endoplasmic reticulum
Vesicles Endometrial cancer:4.30e-4 (unfavourable) Group enriched Tissue enriched 62 pancreas: 6299.8 small intestine: 101.1 PTDSS1 KIAA0024, PSS1, PSSA ENSG00000156471 Phosphatidylserine synthase 1 8 96261715-96336995 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level HPA016852 Uncertain Approved Nucleoplasm
Endoplasmic reticulum Liver cancer:1.08e-5 (unfavourable), Lung cancer:9.83e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 13.9 PVRIG C7orf15, MGC2463 ENSG00000213413 Poliovirus receptor related immunoglobulin domain containing 7 100218241-100221490 Predicted membrane proteins Evidence at transcript level HPA047497 Uncertain Approved Nucleoli
Endoplasmic reticulum Not detected Tissue enhanced lymph node: 20.8;spleen: 11.3 appendix: 8.8 RAB1A RAB1, YPT1 ENSG00000138069 RAB1A, member RAS oncogene family 2 65070701-65130106 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB005331, HPA056141 Approved Supported Endoplasmic reticulum
Cytosol Head and neck cancer:4.19e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 217.2 RAB1B ENSG00000174903 RAB1B, member RAS oncogene family 11 66268533-66277492 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB010225, HPA056141 Approved Supported Endoplasmic reticulum
Golgi apparatus Renal cancer:1.09e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 181.5 RARRES1 LXNL, TIG1 ENSG00000118849 Retinoic acid receptor responder (tazarotene induced) 1 3 158696892-158732696 Predicted secreted proteins Evidence at protein level HPA003892 Uncertain Approved Endoplasmic reticulum
Golgi apparatus Renal cancer:5.88e-6 (unfavourable) Expressed in all Mixed appendix: 80.1 RCN3 RLP49 ENSG00000142552 Reticulocalbin 3, EF-hand calcium binding domain 19 49527618-49546962 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA043134, HPA050402 Uncertain Approved Endoplasmic reticulum
Vesicles Renal cancer:5.80e-12 (unfavourable) Expressed in all Expressed in all small intestine: 46.0 RPL10 DXS648, DXS648E, FLJ23544, L10, NOV, QM ENSG00000147403 Ribosomal protein L10 X 154389955-154409168 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level CAB010339, HPA011311 Supported Validated Endoplasmic reticulum
Cytosol Renal cancer:7.67e-6 (unfavourable) Expressed in all Expressed in all ovary: 9655.2 RPL10L ENSG00000165496 Ribosomal protein L10-like 14 46651010-46651821 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA011311 Uncertain Approved Endoplasmic reticulum
Cytosol Tissue enriched Tissue enriched 44 testis: 126.2 rectum: 2.8 RPL14 CTG-B33, hRL14, L14, RL14 ENSG00000188846 Ribosomal protein L14 3 40457292-40468587 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA004136 Approved Supported Endoplasmic reticulum
Cytosol Expressed in all Expressed in all breast: 311.2 RPL17 L17, rpL23 ENSG00000265681 Ribosomal protein L17 18 49488453-49492523 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA043724, HPA046385 Supported Supported Endoplasmic reticulum
Cytosol Liver cancer:3.60e-5 (unfavourable) Expressed in all Expressed in all ovary: 4386.6 RPL17-C18orf32 ENSG00000215472 RPL17-C18orf32 readthrough 18 49481681-49492479 Predicted intracellular proteins Evidence at protein level HPA043724, HPA046385 Approved Supported Endoplasmic reticulum
Cytosol Not detected Expressed in all cerebral cortex: 66.4 RPL24 L24 ENSG00000114391 Ribosomal protein L24 3 101681091-101686782 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA051653 Approved Validated Endoplasmic reticulum
Cytosol Renal cancer:2.72e-5 (unfavourable), Thyroid cancer:8.25e-4 (favourable) Expressed in all Expressed in all ovary: 2886.8 RPL27A L27A ENSG00000166441 Ribosomal protein L27a 11 8682411-8714759 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA060776, HPA063379 Supported Supported Endoplasmic reticulum
Cytosol Renal cancer:2.83e-10 (unfavourable), Breast cancer:7.84e-5 (favourable) Expressed in all Expressed in all lymph node: 2865.3 RPL28 FLJ43307, L28 ENSG00000108107 Ribosomal protein L28 19 55385345-55403250 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA050459 Approved Supported Endoplasmic reticulum
Cytosol Renal cancer:6.61e-5 (unfavourable) Expressed in all Expressed in all lymph node: 2004.1 RPL30 L30 ENSG00000156482 Ribosomal protein L30 8 98024851-98046469 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA002651 Approved Approved Endoplasmic reticulum
Cytosol Renal cancer:1.41e-9 (unfavourable) Expressed in all Expressed in all ovary: 5893.2 RPL32 L32 ENSG00000144713 Ribosomal protein L32 3 12834485-12841588 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA047501, HPA051994 Approved Approved Endoplasmic reticulum
Cytosol Expressed in all Expressed in all ovary: 4499.5 RPL35 L35 ENSG00000136942 Ribosomal protein L35 9 124857880-124861981 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA006047 Approved Approved Endoplasmic reticulum
Cytosol Expressed in all Expressed in all ovary: 2745.4 RPL36 DKFZp566B023, L36 ENSG00000130255 Ribosomal protein L36 19 5674947-5691876 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA047153 Supported Uncertain Endoplasmic reticulum
Cytosol Renal cancer:2.32e-4 (unfavourable) Expressed in all Expressed in all ovary: 2366.8 RPL37A L37A ENSG00000197756 Ribosomal protein L37a 2 216498189-216579180 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA065327 Approved Approved Endoplasmic reticulum
Cytosol Renal cancer:1.14e-4 (unfavourable) Expressed in all Expressed in all ovary: 4507.8 RPL38 L38 ENSG00000172809 Ribosomal protein L38 17 74203582-74210655 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA052543 Approved Supported Endoplasmic reticulum
Cytosol Renal cancer:6.17e-8 (unfavourable), Head and neck cancer:2.51e-4 (unfavourable) Expressed in all Expressed in all ovary: 2575.5 RPLP0 L10E, LP0, P0, PRLP0, RPP0 ENSG00000089157 Ribosomal protein, large, P0 12 120196686-120201235 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA003512 Approved Supported Endoplasmic reticulum
Cytosol Renal cancer:7.66e-12 (unfavourable) Expressed in all Expressed in all breast: 2849.3 RPLP1 LP1 ENSG00000137818 Ribosomal protein, large, P1 15 69452784-69456194 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA003368 Uncertain Validated Endoplasmic reticulum
Cytosol Renal cancer:2.30e-9 (unfavourable) Expressed in all Expressed in all ovary: 1839.8 RPS14 EMTB, S14 ENSG00000164587 Ribosomal protein S14 5 150443190-150449756 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA018504 Uncertain Validated Endoplasmic reticulum
Cytosol Liver cancer:7.73e-4 (unfavourable), Renal cancer:8.69e-4 (unfavourable) Expressed in all Expressed in all fallopian tube: 1979.7 RPS15 MGC111130, RIG, S15 ENSG00000115268 Ribosomal protein S15 19 1438358-1440494 Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA054510, HPA057793 Supported Approved Endoplasmic reticulum
Cytosol Expressed in all Expressed in all ovary: 1335.1 RPS16 S16 ENSG00000105193 Ribosomal protein S16 19 39433207-39435948 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA064222 Approved Validated Endoplasmic reticulum
Cytosol Expressed in all Expressed in all ovary: 3699.3 RPS2 LLREP3, S2 ENSG00000140988 Ribosomal protein S2 16 1962052-1964860 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA055133 Approved Approved Endoplasmic reticulum
Cytosol Renal cancer:3.04e-7 (unfavourable), Liver cancer:7.70e-4 (unfavourable) Expressed in all Expressed in all ovary: 3061.1 RPS20 S20 ENSG00000008988 Ribosomal protein S20 8 56067295-56074581 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA003570 Approved Supported Endoplasmic reticulum
Cytosol Renal cancer:1.21e-8 (unfavourable) Expressed in all Expressed in all ovary: 4357.5 RPS21 S21 ENSG00000171858 Ribosomal protein S21 20 62387116-62388520 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA003371 Approved Validated Endoplasmic reticulum
Cytosol Liver cancer:8.46e-4 (unfavourable) Expressed in all Expressed in all ovary: 2347.4 RPS23 S23 ENSG00000186468 Ribosomal protein S23 5 82273358-82278577 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA054853 Approved Validated Endoplasmic reticulum
Cytosol Renal cancer:2.17e-4 (unfavourable), Liver cancer:4.72e-4 (unfavourable) Expressed in all Expressed in all ovary: 4311.4 RPS25 S25 ENSG00000118181 Ribosomal protein S25 11 119015712-119018691 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA031801 Approved Approved Endoplasmic reticulum
Cytosol Renal cancer:3.00e-7 (unfavourable) Expressed in all Expressed in all ovary: 944.6 RPS29 S29 ENSG00000213741 Ribosomal protein S29 14 49570984-49599164 Disease related genes, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA004107 Approved Supported Endoplasmic reticulum
Cytosol Breast cancer:2.66e-4 (favourable) Expressed in all Expressed in all breast: 3614.6 RPS3 FLJ26283, FLJ27450, MGC87870, S3 ENSG00000149273 Ribosomal protein S3 11 75399486-75422280 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA063339 Uncertain Supported Endoplasmic reticulum
Cytosol Renal cancer:6.92e-6 (unfavourable) Expressed in all Expressed in all ovary: 3526.1 RPS5 S5 ENSG00000083845 Ribosomal protein S5 19 58386400-58394806 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA055878, HPA061979 Supported Supported Endoplasmic reticulum
Cytosol Liver cancer:1.12e-5 (unfavourable), Renal cancer:4.75e-4 (unfavourable) Expressed in all Expressed in all ovary: 2644.2 RPS6 S6 ENSG00000137154 Ribosomal protein S6 9 19375715-19380254 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level CAB004027, HPA031153 Supported Validated Endoplasmic reticulum
Cytosol Endometrial cancer:4.12e-4 (favourable) Expressed in all Expressed in all ovary: 4794.1 RPS7 S7 ENSG00000171863 Ribosomal protein S7 2 3575205-3580919 Disease related genes, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA056586 Approved Approved Endoplasmic reticulum
Cytosol Renal cancer:1.34e-8 (unfavourable), Liver cancer:5.27e-4 (unfavourable) Expressed in all Expressed in all ovary: 2607.1 RPS8 S8 ENSG00000142937 Ribosomal protein S8 1 44775251-44778779 Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA029266 Supported Endoplasmic reticulum
Cytosol Renal cancer:9.05e-9 (unfavourable), Liver cancer:2.36e-5 (unfavourable) Expressed in all Expressed in all ovary: 5531.8 RSAD2 cig5, vig1, viperin ENSG00000134321 Radical S-adenosyl methionine domain containing 2 2 6865806-6898239 Predicted intracellular proteins Evidence at protein level HPA041160, HPA049409 Approved Supported Nucleoli fibrillar center
Endoplasmic reticulum Endometrial cancer:4.60e-4 (unfavourable) Expressed in all Mixed spleen: 18.0 SARAF MGC8721, TMEM66 ENSG00000133872 Store-operated calcium entry-associated regulatory factor 8 30063012-30083208 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA040400 Supported Endoplasmic reticulum
Rods & Rings Lung cancer:5.28e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 287.8 SBF1 DENND7A, MTMR5 ENSG00000100241 SET binding factor 1 22 50445000-50475024 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA065538 Approved Endoplasmic reticulum
Vesicles Head and neck cancer:3.46e-5 (favourable) Expressed in all Expressed in all testis: 84.3 SEC16A KIAA0310, p250, Sec16L ENSG00000148396 SEC16 homolog A, endoplasmic reticulum export factor 9 136440096-136483759 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA005684 Supported Supported Endoplasmic reticulum
Golgi apparatus Endometrial cancer:1.30e-6 (favourable), Renal cancer:4.47e-4 (favourable) Expressed in all Expressed in all stomach: 26.6 SEC62 Dtrp1, HTP1, TLOC1 ENSG00000008952 SEC62 homolog, preprotein translocation factor 3 169966635-169998373 Predicted membrane proteins Evidence at protein level HPA014059, HPA061450 Approved Approved Endoplasmic reticulum
Intermediate filaments Expressed in all Expressed in all thyroid gland: 202.4 SEMA4D C9orf164, CD100, coll-4, FLJ39737, SEMAJ ENSG00000187764 Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D 9 89360787-89498130 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA015662, HPA023277 Approved Supported Endoplasmic reticulum
Vesicles Urothelial cancer:4.06e-5 (favourable), Cervical cancer:4.17e-4 (favourable) Expressed in all Expressed in all lymph node: 73.3 SERPINB7 MEGSIN ENSG00000166396 Serpin peptidase inhibitor, clade B (ovalbumin), member 7 18 63752935-63805376 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA024200 Approved Approved Endoplasmic reticulum
Mitochondria Pancreatic cancer:3.03e-5 (unfavourable) Mixed Tissue enhanced skin: 123.8;tonsil: 35.5 breast: 17.2 STMN2 SCG10, SCGN10 ENSG00000104435 Stathmin 2 8 79610814-79666175 Predicted intracellular proteins Evidence at protein level HPA026922 Supported Approved Endoplasmic reticulum
Vesicles Group enriched Tissue enriched 6 cerebral cortex: 490.7 adrenal gland: 88.6 TAP1 ABCB2, D6S114E, PSF1, RING4 ENSG00000168394 Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) 6 32845209-32853978 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level CAB009516, HPA072354 Approved Supported Endoplasmic reticulum
Microtubule organizing center Renal cancer:6.58e-5 (unfavourable), Ovarian cancer:4.07e-4 (favourable), Colorectal cancer:9.01e-4 (favourable) Expressed in all Mixed appendix: 20.6 TAP2 ABCB3, D6S217E, PSF2, RING11 ENSG00000204267 Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) 6 32821833-32838780 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA001312 Approved Approved Nuclear speckles
Endoplasmic reticulum Renal cancer:5.22e-8 (unfavourable), Pancreatic cancer:1.51e-4 (unfavourable) Expressed in all Mixed urinary bladder: 15.7 TM7SF2 ANG1, DHCR14A, NET47 ENSG00000149809 Transmembrane 7 superfamily member 2 11 65111845-65116384 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA030691, HPA072704 Approved Supported Endoplasmic reticulum
Vesicles Renal cancer:8.49e-8 (favourable) Expressed in all Expressed in all adrenal gland: 161.3 TMEM133 AD031 ENSG00000170647 Transmembrane protein 133 11 100991989-100993941 Predicted membrane proteins Evidence at protein level HPA060528, HPA065742 Uncertain Approved Endoplasmic reticulum
Golgi apparatus Pancreatic cancer:1.76e-4 (unfavourable) Expressed in all Mixed placenta: 18.2 TMEM14A C6orf73, PTD011 ENSG00000096092 Transmembrane protein 14A 6 52671109-52686588 Predicted membrane proteins Evidence at protein level HPA072536 Approved Nucleoplasm
Endoplasmic reticulum Expressed in all Expressed in all cerebral cortex: 88.4 TMEM212 FLJ23172 ENSG00000186329 Transmembrane protein 212 3 171843349-171938715 Predicted membrane proteins Evidence at transcript level HPA045736, HPA053134 Uncertain Approved Nucleoli fibrillar center
Endoplasmic reticulum Not detected Tissue enriched 6 fallopian tube: 47.9 lung: 7.7 TMEM259 ASBABP1, C19orf6, MBRL, MGC4022 ENSG00000182087 Transmembrane protein 259 19 1009648-1021179 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA042669, HPA054801 Approved Approved Nuclear speckles
Endoplasmic reticulum Stomach cancer:8.92e-6 (favourable), Endometrial cancer:1.01e-4 (favourable) Expressed in all Expressed in all spleen: 132.3 TMEM27 NX17 ENSG00000147003 Transmembrane protein 27 X 15627318-15665031 Predicted membrane proteins, Transporters Evidence at protein level HPA048543 Approved Approved Endoplasmic reticulum
Vesicles Renal cancer:6.78e-9 (favourable), Ovarian cancer:5.65e-4 (favourable) Tissue enriched Tissue enriched 16 kidney: 418.5 parathyroid gland: 26.1 TMX1 PDIA11, TMX, TXNDC, TXNDC1 ENSG00000139921 Thioredoxin-related transmembrane protein 1 14 51240162-51257546 Predicted membrane proteins Evidence at protein level HPA003085 Approved Supported Nucleoli
Endoplasmic reticulum Liver cancer:1.29e-6 (unfavourable) Expressed in all Expressed in all thyroid gland: 19.8 TP53I11 PIG11 ENSG00000175274 Tumor protein p53 inducible protein 11 11 44885903-44951306 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA059727, HPA061276 Uncertain Supported Endoplasmic reticulum
Golgi apparatus Breast cancer:7.33e-5 (unfavourable), Renal cancer:4.65e-4 (unfavourable), Melanoma:6.12e-4 (unfavourable) Expressed in all Expressed in all adipose tissue: 58.0 TPTE CT44, PTEN2 ENSG00000274391 Transmembrane phosphatase with tensin homology 21 10521553-10606140 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA049690, HPA068342 Supported Approved Endoplasmic reticulum
Cytosol Tissue enriched Tissue enriched 225 testis: 198.9 epididymis,placenta: 0.8 TPTE2 TPIP ENSG00000132958 Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 13 19422877-19536762 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level HPA068342 Approved Endoplasmic reticulum
Cytosol Tissue enriched Tissue enriched 33 testis: 11.9 lymph node,tonsil: 0.3 TRAK1 KIAA1042, MILT1, OIP106 ENSG00000182606 Trafficking protein, kinesin binding 1 3 42013802-42225889 Predicted intracellular proteins Evidence at protein level HPA005853, HPA011367 Approved Approved Nucleoplasm
Endoplasmic reticulum Renal cancer:4.84e-8 (favourable) Expressed in all Expressed in all heart muscle: 111.9 TRIM61 RNF35 ENSG00000183439 Tripartite motif containing 61 4 164954446-164977668 Predicted intracellular proteins Evidence at transcript level HPA049109 Uncertain Approved Nucleoli fibrillar center
Endoplasmic reticulum Tissue enhanced Tissue enhanced testis: 10.5 thyroid gland: 4.3 UBXN8 D8S2298E, REP8, UBXD6 ENSG00000104691 UBX domain protein 8 8 30732247-30767006 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA017725, HPA077538 Approved Supported Nucleoli
Endoplasmic reticulum Renal cancer:5.25e-5 (unfavourable), Colorectal cancer:6.13e-4 (favourable) Expressed in all Expressed in all ovary: 109.4 UTP15 FLJ12787, FLJ23637, NET21 ENSG00000164338 UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) 5 73565443-73583377 Predicted intracellular proteins Evidence at protein level HPA044697 Supported Nucleoli
Endoplasmic reticulum Expressed in all Expressed in all bone marrow: 23.2 VMP1 EPG3, TANGO5, TMEM49 ENSG00000062716 Vacuole membrane protein 1 17 59707192-59842255 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA030773, HPA064780 Uncertain Approved Nucleoli
Endoplasmic reticulum Renal cancer:2.77e-8 (unfavourable), Endometrial cancer:1.56e-5 (unfavourable), Liver cancer:8.02e-4 (unfavourable) Expressed in all Expressed in all spleen: 64.7 VTN VN ENSG00000109072 Vitronectin 17 28367276-28373091 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level CAB016695, CAB016765, HPA060933 Supported Supported Endoplasmic reticulum
Vesicles Renal cancer:4.10e-11 (unfavourable), Liver cancer:3.74e-4 (favourable) Tissue enriched Tissue enriched 28 liver: 2540.4 gallbladder: 91.6 XPR1 SYG1, X3 ENSG00000143324 Xenotropic and polytropic retrovirus receptor 1 1 180632004-180890251 Disease related genes, Predicted membrane proteins Evidence at protein level HPA016557 Supported Approved Endoplasmic reticulum
Golgi apparatus Liver cancer:3.04e-4 (unfavourable) Expressed in all Expressed in all testis: 31.1 XXbac-BPG246D15.9 ENSG00000250264 6 32813767-32838822 Predicted membrane proteins Evidence at transcript level HPA001312 Approved Approved Nuclear speckles
Endoplasmic reticulum Not detected Tissue enhanced appendix: 16.0;spleen: 9.7 lymph node: 6.6 ZMYM2 FIM, MYM, RAMP, ZNF198 ENSG00000121741 Zinc finger, MYM-type 2 13 19958670-20091829 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level HPA031765 Approved Approved Nucleoplasm
Endoplasmic reticulum Urothelial cancer:6.07e-4 (favourable) Expressed in all Expressed in all testis: 87.6 ZNF33A FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK ENSG00000189180 Zinc finger protein 33A 10 38010650-38065088 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005538, HPA056638 Approved Uncertain Nucleoli
Endoplasmic reticulum Expressed in all Expressed in all parathyroid gland: 34.5 ZNF33B KOX2, KOX31, ZNF11B ENSG00000196693 Zinc finger protein 33B 10 42574185-42638568 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA005538, HPA056638 Approved Uncertain Nucleoli
Endoplasmic reticulum Expressed in all Expressed in all fallopian tube: 31.9